1-7 of 7
Mehak M Laharwal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of BCMA T-Cell Engagers (TCE) Vs. Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Following BCMA-Directed Therapies, Relapsed/Refractory Multiple Myeloma: The Chicken or the Egg Dilemma

Jordan Snyder, Nausheen Ahmed, Zahra Mahmoudjafari, Al-Ola Abdallah, Joseph P. McGuirk, Muhammad Umair Mushtaq, Alma Habib, Abdullah Mohammad Khan, Mehak M Laharwal, Prerna Mewawalla, Marshall McKenna, Yun Kyoung Tiger, Hira Shaikh, Andrew Vegel, Emily Struble, Jonathan Lochner, Christopher Strouse, Kimberly M Green, James A Davis, Hamza Hashmi, Shebli Atrash, Reed Friend, Barry Paul
Journal: Blood
Blood (2024) 144 (Supplement 1): 7098.
https://doi.org/10.1182/blood-2024-207398
Published: 2024
Journal Articles

Use of Doublet Maintenance (Bortezomib-Lenalidomide) Vs Monotherapy Lenalidomide As Maintenance Therapy Post-Transplant of Patients with High-Risk Cytogenetics Myeloma

Mehak M Laharwal, Jordan Snyder, Aroog Khaliq, Raeef L Rahman, Shebli Atrash, Muhammad Umair Mushtaq, Al-Ola Abdallah, Nausheen Ahmed, Prerna Mewawalla
Journal: Blood
Blood (2024) 144 (Supplement 1): 7017.
https://doi.org/10.1182/blood-2024-201907
Published: 2024
Journal Articles

Outcomes of Double-Hit and Single High Risk Cytogenetic Newly Diagnosed Myeloma in Transplant Eligible Patients

Raeef L Rahman, Aroog Khaliq, Mehak M Laharwal, Shebli Atrash, Joseph P. McGuirk, Zahra Mahmoudjafari, Muhammad Umair Mushtaq, Al-Ola Abdallah, Nausheen Ahmed, Prerna Mewawalla, Jordan Snyder
Journal: Blood
Blood (2024) 144 (Supplement 1): 6953.
https://doi.org/10.1182/blood-2024-206098
Published: 2024
Journal Articles

Characterizing Treatment Patterns in Multiple Myeloma Patients with High-Risk Cytogenetics: A 15-Year-Study

Priyanka Venkatesh, Raeef L Rahman, Aroog Khaliq, Mehak M Laharwal, Shebli Atrash, Joseph P. McGuirk, Forat Lutfi, Muhammad Umair Mushtaq, Al-Ola Abdallah, Nausheen Ahmed, Prerna Mewawalla, Jordan Snyder, Zahra Mahmoudjafari
Journal: Blood
Blood (2024) 144 (Supplement 1): 6943.
https://doi.org/10.1182/blood-2024-211572
Published: 2024
Journal Articles

A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment

Alma Habib, Abdullah Mohammad Khan, Mehak M Laharwal, Prerna Mewawalla, Marshall McKenna, Yun Kyoung Tiger, Hira Shaikh, Christopher Strouse, Kimberly M Green, James A Davis, Hamza Hashmi, Jordan Snyder, Zahra Mahmoudjafari, Muhammad Umair Mushtaq, Nausheen Ahmed, Al-Ola Abdallah, Shebli Atrash, Barry Paul, Reed Friend
Journal: Blood
Blood (2024) 144 (Supplement 1): 7037.
https://doi.org/10.1182/blood-2024-209283
Published: 2024
Journal Articles

Evaluation of Teclistamab in BCMA-Directed Therapy Exposed Versus Naïve in Relapsed/Refractory Multiple Myeloma

Jordan Snyder, Kevin Graf, James A Davis, Marshall McKenna, Yun Kyoung Tiger, Mehak M Laharwal, Prerna Mewawalla, Omar Alkharabsheh, Hamza Hashmi, Hira Shaikh, Jonathan Lochner, Darryl Chang, Shebli Atrash, Alma Habib, Priyanka Venkatesh, Zahra Mahmoudjafari, Nausheen Ahmed, Muhammad Umair Mushtaq, Al-Ola Abdallah, Kimberly M Green, Abdullah Mohammad Khan
Journal: Blood
Blood (2024) 144 (Supplement 1): 2411.7.
https://doi.org/10.1182/blood-2024-204158
Published: 2024
Journal Articles

Predictors of Response to Rituximab in Chronic Immune Thrombocytopenia: Do Race, Gender and ABO Blood Type Matter?

Mehak M Laharwal, Ryan Sweeney, Yazan Samhouri, Deep Shah
Journal: Blood
Blood (2023) 142 (Supplement 1): 7304.
https://doi.org/10.1182/blood-2023-180186
Published: 2023